Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ousia Pharma ApS
APS
Active
CVR 43055909
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 4 years old
8 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ousia Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2022
-2M
2023
-4M
2024
EBITDA
DKK millions
0M
-2M
-4M
-6M
-8M
-1M
2022
-4M
-300%
2023
-6M
-50%
2024
Income statement
DKK thousands
Item
2022
2023
2024
Gross profit
-645
-2.240
-3.656
Staff expenses
-450
-2.064
-2.016
EBITDA
-1.095
-4.304
-5.672
Depreciation & amort.
-0
-0
-0
EBIT
-1.095
-4.304
-5.672
Net financials
-110
-232
-510
Profit before tax
-1.205
-4.536
-6.181
Tax
-301
-789
-833
Net profit
-904
-3.747
-5.349
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
3.280
5.798
5.090
Equity
-864
-4.738
-10.087
Long-term debt
4.090
10.314
10.841
Short-term debt
54
223
4.336
Total debt
4.144
10.537
15.177
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-567194400.0%
This company
2022
2024
Equity ratio
-198.2%
This company
38.2%
Market median
-619% vs market
2022
2024
Return on equity
-534857900.0%
This company
18.4%
Market median
-2906836513% vs market
2022
2024
Net profit margin (of gross profit)
-534857900.0%
This company
2022
2024
Asset turnover (of gross profit)
-0.72×
This company
2022
2024
Debt / equity
1.50×
This company
0.62×
Market median
-142% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-02-14 – 2022-12-31
View
PDF
More on Ousia Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
